To include your compound in the COVID-19 Resource Center, submit it here.

Onyx regains remaining ONYX-015 rights

ONXX said it regained from Warner-Lambert, a subsidiary

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE